On Tuesday, West Pharmaceutical Services, Inc. (NYSE: WST) opened lower -3.14% from the last session, before settling in for the closing price of $328.73. Price fluctuations for WST have ranged from $310.42 to $415.73 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 11.96% over the last five years. Company’s average yearly earnings per share was noted -4.00% at the time writing. With a float of $72.43 million, this company’s outstanding shares have now reached $73.50 million.
The firm has a total of 10600 workers. Let’s measure their productivity.
West Pharmaceutical Services, Inc. (WST) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of West Pharmaceutical Services, Inc. is 0.57%, while institutional ownership is 95.90%. The most recent insider transaction that took place on May 07 ’24, was worth 24,199,050. In this transaction President, CEO and Board Chair of this company sold 66,000 shares at a rate of $366.65, taking the stock ownership to the 152,908 shares. Before that another transaction happened on Mar 11 ’24, when Company’s VP, Chief Accounting Officer sold 815 for $358.82, making the entire transaction worth $292,436. This insider now owns 1,309 shares in total.
West Pharmaceutical Services, Inc. (WST) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -4.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.87% during the next five years compared to 23.49% growth over the previous five years of trading.
West Pharmaceutical Services, Inc. (NYSE: WST) Trading Performance Indicators
Check out the current performance indicators for West Pharmaceutical Services, Inc. (WST). In the past quarter, the stock posted a quick ratio of 1.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.92. Likewise, its price to free cash flow for the trailing twelve months is 60.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.58, a number that is poised to hit 1.74 in the next quarter and is forecasted to reach 9.08 in one year’s time.
Technical Analysis of West Pharmaceutical Services, Inc. (WST)
Analysing the last 5-days average volume posted by the [West Pharmaceutical Services, Inc., WST], we can find that recorded value of 0.54 million was better than the volume posted last year of 0.52 million. As of the previous 9 days, the stock’s Stochastic %D was 24.22%. Additionally, its Average True Range was 9.33.
During the past 100 days, West Pharmaceutical Services, Inc.’s (WST) raw stochastic average was set at 1.47%, which indicates a significant decrease from 3.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 23.80% in the past 14 days, which was lower than the 36.49% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $365.42, while its 200-day Moving Average is $366.70. Now, the first resistance to watch is $327.36. This is followed by the second major resistance level at $336.29. The third major resistance level sits at $341.47. If the price goes on to break the first support level at $313.24, it is likely to go to the next support level at $308.06. Now, if the price goes above the second support level, the third support stands at $299.13.
West Pharmaceutical Services, Inc. (NYSE: WST) Key Stats
There are currently 72,843K shares outstanding in the company with a market cap of 23.19 billion. Presently, the company’s annual sales total 2,950 M according to its annual income of 593,400 K. Last quarter, the company’s sales amounted to 695,400 K and its income totaled 115,300 K.
